In vitro cytotoxicity and phototoxicity of N-piperazinyl quinolone derivatives with a 2-thienyl group

Toxicology in Vitro

Volumn 21, Issue 6, 2007, Pages 1031-1038

  Pardakhty, Abbas ^a   Foroumadi, Alireza ^b,c   Hashemi, Mehdi ^d   Rajabalian, Saeed ^b   Heidari, Mahmoud Reza ^b,d  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d Faculty of Pharmacy   (Iran)

Author keywords

Cytotoxicity; Fluoroquinolones; Phototoxicity

Indexed keywords

1 CYCLOPROPYL 6 FLUORO 1,4 DIHYDRO 7 [4 [2 (2 THIENYL) 2 (PHENYLMETHOXYIMINO)ETHYL]PIPERAZIN 1 YL] 4 OXO 3 QUINOLONE CARBOXYLIC ACID; 1 CYCLOPROPYL 6 FLUORO 1,4 DIHYDRO 7 [4 [2 (2 THIENYL) 2 OXOETHYL]PIPERAZIN 1 YL] 4 OXO 3 QUINOLONE CARBOXYLIC ACID; 1 ETHYL 6 FLUORO 1,4 DIHYDRO 7 [4 [2 (2 THIENYL) 2 (HYDROXYIMINO)ETHYL]PIPERAZIN 1 YL] 4 OXO 1,8 NAPHTHYRIDINE 3 CARBOXYLIC ACID; 1 ETHYL 6 FLUORO 1,4 DIHYDRO 7 [4 [2 (2 THIENYL) 2 (METHOXYIMINO)ETHYL]PIPERAZIN 1 YL] 4 OXO 1,8 NAPHTHYRIDINE 3 CARBOXYLIC ACID; 1 ETHYL 6 FLUORO 1,4 DIHYDRO 7 [4 [2 (2 THIENYL) 2 (METHOXYIMINO)ETHYL]PIPERAZIN 1 YL] 4 OXO 3 QUINOLONE CARBOXYLIC ACID; 1 ETHYL 6 FLUORO 1,4 DIHYDRO 7 [4 [2 (2 THIENYL) 2 (PHENYLMETHOXYIMINO)ETHYL]PIPERAZIN 1 YL] 4 OXO 1,8 NAPHTHYRIDINE 3 CARBOXYLIC ACID; 1 ETHYL 6 FLUORO 1,4 DIHYDRO 7 [4 [2 (2 THIENYL) 2 (PHENYLMETHOXYIMINO)ETHYL]PIPERAZIN 1 YL] 4 OXO 3 QUINOLONE CARBOXYLIC ACID; 1 ETHYL 6 FLUORO 1,4 DIHYDRO 7 [4 [2 (2 THIENYL) 2 OXOETHYL]PIPERAZIN 1 YL] 4 OXO 1,8 NAPHTHYRIDINE 3 CARBOXYLIC ACID; 1 ETHYL 6 FLUORO 1,4 DIHYDRO 7 [4 [2 (2 THIENYL) 2 OXOETHYL]PIPERAZIN 1 YL] 4 OXO 3 QUINOLONE CARBOXYLIC ACID; CHLORPROMAZINE; CIPROFLOXACIN; ENOXACIN; ETOPOSIDE; NORFLOXACIN; PIPERAZINE DERIVATIVE; QUINOLONE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL STRAIN 3T3; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; MOUSE; MOUTH CARCINOMA; MOUTH MUCOSA; NONHUMAN; PHOTOTOXICITY; SQUAMOUS CELL CARCINOMA; TOXICITY TESTING; ULTRAVIOLET A RADIATION;

3T3 CELLS; ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL SURVIVAL; HUMANS; MICE; QUINOLONES; ULTRAVIOLET RAYS;

EID: 34547731379     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2007.03.011     Document Type: Article

References (42)

1. Burstein N.L. Corneal cytotoxicity of topically applied drugs, vehicles and preservatives. Survey of Ophthalmology 25 (1980) 15-30
2. Cooper C.S., Tufano M.D., Donner P.K., and Chu D.T. The synthesis and in vitro antibacterial activity of conformationally restricted quinolone antibacterial agents. Bioorganic and Medicinal Chemistry 4 (1996) 1307-1315
3. Dijoux C., Guingand Y., Bourgeois C., Durand S., Fromageot C., Combe C., and Ferret F.J. Assessment of the phototoxic hazard of some essential oils using modified 3T3 neutral red uptake assay. Toxicology in Vitro 20 (2006) 480-489
4. Domagala J.M., Hanna L.D., Heifetz C.L., Hutt M.P., Mich T.F., Sanchez J.P., and Solomon M. New structure-activity relationships of the quinolone antibacterials using the target enzyme. The development and application of a DNA gyrase assay. Journal of Medicinal Chemistry 29 (1986) 394-404
5. Duffy P.A., Bennett A., Roberts M., and Flint O.P. The prediction of phototoxic potential using human A431 cells and mouse 3T3 cells. In: Goldberg A.M. (Ed). Alternative Methods in Toxicology Series. In vitro Toxicology: New Directions vol. 7 (1989), Mary Ann Liebert Inc, New York 327-335
6. Elsea S.H., Osheroff N., and Nitiss J.L. Cytotoxicity of quinolones toward eukaryotic cells: Identification of topoisomerase II as the primary cellular target for the quinolone CP-115,953 in yeast. The Journal of Biological Chemistry 267 (1992) 13150-13153
7. Emami S., Shafiee A., and Foroumadi A. Structural features of new quinolones and relationship to antibacterial activity against gram-positive bacteria. Mini-Reviews in Medicinal Chemistry 6 (2006) 375-386
8. Fang K.C., Chen Y.L., Sheu J.Y., Wang T.C., and Tzeng C.C. Synthesis, antibacterial and cytotoxic evaluation of certain 7-substituted norfloxacin derivatives. Journal of Medicinal Chemistry 43 (2000) 3809-3812
9. Ferguson J. Phototoxicity due to fluoroquinolones. In: Hooper D.C., and Rubinstein E. (Eds). Quinolone Antimicrobial Agents (2003), ASM Press, Washington, DC 451-460
10. Ferguson, J., McEwen, J., Patterson, B.E., Purkins, L., Colman, P.J., Willavize, S.A., 1996. An open, observer-blinded, placebo controlled, randomized parallel-group study to investigate the phototoxic potential of trovafloxacin, ciprofloxacin and lomefloxacin. In: 36th Inter-science Conference on Antimicrobial Agents and Chemotherapy, New Orleans. Abstract No. A15.
11. Foroumadi A., Mansouri S., Kiani Z., and Rahmani A. Synthesis and in vitro antibacterial evaluation of N-[5-(5-nitro-2-thienyl)-1,3,4-thiadiazole-2-yl] piperazinyl quinolones. European Journal of Medicinal Chemistry 38 (2003) 851-854
12. Foroumadi A., Emami S., Hassanzadeh A., Rajaee M., Sokhanvar K., Moshafi M.H., and Shafiee A. Synthesis and antibacterial activity of N-(5-benzylthio-1,3,4-thiadiazol-2-yl) and N-(5-benzylsulfonyl-1,3,4-thiadiazol-2-yl) piperazinyl quinolone derivatives. Bioorganic & Medicinal Chemistry Letters 15 (2005) 4488-4492
13. Gootz T.D., McGuirk P.R., Moynihan M.S., and Haskell S.L. Placement of alkyl substituents on the C-7 piperazine ring of fluoroquinolones: dramatic differential effects on mammalian topoisomerase II and DNA gyrase. Antimicrobial Agents and Chemotherapy 38 (1994) 130-133
14. Gürbay A., Gonthier B., Signorini-Allibe N., Barret L., Favier A., and Hi{dotless}ncal F. Ciprofloxacin-induced DNA damage in primary culture of rat astrocytes and protection by vitamin E. Neurotoxicology 27 (2006) 6-10
15. Hayashi N., Nakata Y., and Yazaki A. New findings on the structure-phototoxicity relationship and photostability of fluoroquinolones with various substituents at position 1. Antimicrobial Agents and Chemotherapy 48 (2004) 799-803
16. Hooper D.C. Mechanisms of action of antimicrobials: focus on fluoroquinolones. Clinical Infectious Diseases 15 (2001) S9-S15
17. Inagaki H., Takahashi H., and Takemura M. Synthesis and antibacterial activity of novel 6-fluoro-1-[(1R,2S)-2-fluorocyclopropan-1-yl]-4-oxoquinoline-3-carboxylic acids bearing cyclopropane-fused 2-amino-8-azabicyclo[4.3.0]nonan-8-yl substituents at the C-7 position. Bioorganic & Medicinal Chemistry Letters 14 (2004) 5193-5198
18. Kobayakawa J., Sato-Nishimori F., Moriyasu M., and Matsukawa Y. G2-M arrest and antimitotic activity mediated by casticin, a flavonoid isolated from Viticis Fructus (Vitex rotundifolia Linne fil.). Cancer Letters 208 (2004) 59-64
19. Lietman P.S. Fluoroquinolone toxicities. An Update Drugs 49 (1995) 159-163
20. Lipsky B.A., and Baker C.A. Fluoroquinolone toxicity profiles: a review focusing on newer agents. Clinical Infectious Diseases 28 (1999) 352-364
21. Lipsky, B.A., Dorr, M.B., Magner, D.J., Talbot, G.H., 1996. Safety profile of sparfloxacin (SPAR) in north American phase III clinical trials. In: 36th Inter-science Conference on Antimicrobial Agents and Chemotherapy, New Orleans. Abstract No. LM13.
22. Mascellino M.T., Farinelli S., Iegri F., Iona E., and De Simone C. Antimicrobial activity of fluoroquinolones and other antibiotics on 1116 clinical gram-positive and gram-negative isolates. Drug Experimental and Clinical Research 24 (1998) 139-151
23. Minta M., Wilk I., and Zmudzki J. Inhibition of cell differentiation by quinolones in micromass cultures of rat embryonic limb bud and midbrain cells. Toxicology in Vitro 19 (2005) 915-919
24. Miolo G., Viola G., Vedaldi D., Dall'Acqua F., Fravolini A., Tabarrini O., and Cecchetti V. In vitro phototoxic properties of new 6-desfluoro and 6-fluoro-8-methylquinolones. Toxicology in Vitro 16 (2002) 683-693
25. Mirzaei M., and Foroumadi A. Synthesis and in-vitro antibacterial activity of N-piperazinyl quinolone derivatives with a 2-thienyl group. Pharmacy & Pharmacology Communications 6 (2000) 351-354
26. Neumann N.J., Blotz A., Wasinska-Kempka G., Rosenbruch M., Lehmann P., Ahr H.J., and Vohr H.-V. Evaluation of phototoxic and photoallergic potentials of 13 compounds by different in vitro and in vivo methods. Journal of Photochemistry and Photobiology B: Biology 79 (2005) 25-34
27. Peters B., and Holzhütter H.-G. In vitro phototoxicity testing: development and validation of a new concentration response analysis software and biostatistical analyses related to the use of various prediction models. ATLA 30 (2002) 415-432
28. Pollack G., McKelvie P., and White J. The in vivo effects of fluoroquinolones on rabbit corneas. Clinical and Experimental Ophthalmology 31 (2003) 517-521
29. Pouzaud F., Bernard-Beaubois K., Thevenin M., Warnet J.-M., Hayem G., and Rat P. In vitro discrimination of fluoroquinolones toxicity on tendon cells: involvement of oxidative stress. The Journal of Pharmacology and Experimental Therapeutics 308 (2004) 394-402
30. Reviglio V.E., Hakim M.A., Song J.K., and O'Brien T.P. Effect of topical fluoroquinolones on the expression of matrix metalloproteinases in the cornea. BMC Ophthalmology 3 10 (2003) 1-8
31. Shen L.L., Mitscher L.A., Sharma P.N., O'Donnell T.J., Chu D.W., Cooper C.S., Rosen T., and Pernet A.G. Mechanism of inhibition of DNA gyrase by quinolone antibacterials: a cooperative drug-DNA binding model. Biochemistry 28 (1989) 3886-3894
32. Shimoda K. Mechanism of quinolone phototoxicity. Toxicology Letters 102 (1998) 369-373
33. Shimoda K., Ikeda T., Okawara S., and Kato M. Possible relationship between phototoxicity and photodegradation of sitafloxacin, a quinolone antibacterial agent, in the auricular skin of albino mice. Toxicological Sciences 56 (2000) 290-296
34. Sissi C., and Palumbo M. The quinolone family: from antibacterial to anticancer agents. Current Medicinal Chemistry - Anti-Cancer Agents 3 (2003) 439-450
35. Spielmann H., Balls M., Brand M., Döring B., Holzhütter H.G., Kalweit S., Klecak G., L'Epattenier H., Liebsch M., Lovell W.W., Maurer T., Moldenhauer F., Moore L., Pape W.J.W., Pfannenbecker U., Potthast J., De Silva O., Steiling W., and Willshaw A. EC/COLIPA project on in vitro phototoxicity testing: first results obtained with the Balb/c 3T3 cell phototoxicity assay. Toxicology in Vitro 8 (1994) 793-796
36. Spielmann H., Balls M., Dupuis J., Pape W.J.W., Pechovitch G., De Silva O., Holzhutter H.G., Clothier R., Desolle P., Gerberick F., Liebsch M., Lovell W.W., Maurer T., Pfannenbecker U., Potthast J.M., Csato M., Sladowski D., Steiling W., and Brantom P. The international EU/COLIPA in vitro phototoxicity validation study: results of Phase II (blind trial); Part 1: the 3T3 NRU phototoxicity test. Toxicology in Vitro 12 (1998) 305-327
37. Suto M.J., Domagala J.M., Roland G.E., Mailloux G.B., and Cohen M.A. Fluoroquinolones: relationships between structural variations, mammalian cell cytotoxicity, and antimicrobial activity. Journal of Medicinal Chemistry 35 (1992) 4745-4750
38. Traynor N.J., Barrat M.D., Lovell W.W., Ferguson J., and Gibbs N.K. Comparison of an in vitro cellular phototoxicity model against controlled clinical trials of fluoroquinolone skin phototoxicity. Toxicology in Vitro 14 (2000) 275-283
39. Trisciuoglio D., Krasnowska E., Maggi A., Pozzi R., Parasassi T., and Sapora O. Phototoxic effect of fluoroquinolones on two human cell lines. Toxicology in Vitro 16 (2002) 449-456
40. Vink S.R., Schellens J.H., van Blitterswijk W.J., and Verheij M. Tumor and normal tissue pharmacokinetics of perifosine, an oral anti-cancer alkylphospholipid. Investigation of New Drugs 23 (2005) 279-286
41. Yabe K., Goto K., Jindo T., Sekiguchi M., and Furuhama K. Structure-phototoxicity relationship in Balb/c mice treated with fluoroquinolone derivatives, followed by ultraviolet-A irradiation. Toxicology Letters 157 (2005) 203-210
42. Yamamoto T., Tsurumaki Y., Takei M., Hosaka M., and Oomori Y. In vitro method for prediction of the phototoxic potentials of fluoroquinolones. Toxicology in Vitro 15 (2001) 721-727